Johnson & Johnson remains a Buy for its stability and consistent dividends, despite short-term price fluctuations and modest ...

NEW YORK, NY / ACCESSWIRE / January 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf ...

Johnson & Johnson shares are down 3% Wednesday on safety concerns that could dim sales prospects for a new heart device, ...

Meta’s decision to eliminate its fact-checking program marks a sharp reversal for the major social media company, quickly ...

Johnson & Johnson closed $26.58 below its 52-week high ($168.85), which the company reached on September 4th.

Building on decades of the Company's Alzheimer's research, two differentiated investigational therapies aim to slow ...

Wells Fargo analyst Larry Biegelsen maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target ...

Andrew Curtin said his wife's death after being diagnosed with mesothelioma was a result of using the company's talc-based ...

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...

Johnson & Johnson (NYSE:JNJ – Get Free Report) was the target of a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 17,570,000 ...

The Man Who Wants to Live Forever introduced many viewers to the Minicircle company, and here's what the organization ...